Leads To Development (L2D) was set up in 2009 to meet a relatively new opportunity in the biotech market – to allow companies to outsource the management and oversight of their preclinical drug development. Since then, L2D has rapidly built its reputation, expanded and strengthened its team, and broadened its services to encompass all non-clinical aspects of development as well as clinical oversight.
The company is now considered a leading expert and has a strong client base across Europe and the US to whom it provides hands-on scientific, regulatory and operational project management support across all stages of drug development.
